Clinical Infectious Diseases

Speed Is Necessary but Not Sufficient: Aligning Direct-from-Blood Diagnostics With Stewardship to Reduce Empiric Broad-Spectrum Antibiotic Use ✅ Just Accepted 🔗 bit.ly/3PtQPdB

IDSA has established a Journals Reader Panel where readers of @CIDJournal, @OFIDJournal and @JIDJournal can give direct feedback to our editors. Apply to join by March 31 to engage directly with editors, learn about new journal initiatives and more: bit.ly/406h4ZG

Still Listening ✅ Just Accepted 🔗 bit.ly/3PqA2bs

Time to Appropriate Therapy and AMR-Attributable Mortality ✅ Just Accepted 🔗 bit.ly/40MfYCT

Burden of respiratory syncytial virus among older adults with an acute respiratory infection: a prospective study in six European countries ✅ Just Accepted 🔗 bit.ly/4stzDDA

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections ✅ Just Accepted 🔗 bit.ly/4bEeEXt

Antibiotics in Hospice: Applying the Four-Quadrant Approach to Improve Patient-Centered Care ✅ Just Accepted 🔗 bit.ly/4rRbLJ1

Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines ✅ Just Accepted 🔗 bit.ly/47gdgZX

Immunomodulation in the Treatment of Disseminated Coccidioidomycosis ✅ Just Accepted 🔗 bit.ly/4t2DY0E

Omadacycline Monotherapy in Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium abscessus: Results From a Phase 2, Double-blind, Randomized, Placebo-controlled Study ✅ Just Accepted 🔗 bit.ly/4lI2Ub1

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa ✅ Just Accepted 🔗 bit.ly/4t0oVEB

Duration of therapy for Pseudomonas aeruginosa bacteremia – a post hoc subgroup analysis from the BALANCE randomized controlled trial ✅ Just Accepted 🔗 bit.ly/4rKKyry

Responding appropriately to safety signals in infants exposed to the 6-month BDLLfx/BDLCfz regimen in utero ✅ Just Accepted 🔗 bit.ly/4duKVms

Composite End Points, Minor Anomalies, and Missed Work-ups: Making 12-Month Infant “Unfavourable Outcomes” Interpretable After BDLLfx/BDLCfz in Pregnancy ✅ Just Accepted 🔗 bit.ly/40H4OiE

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients ✅ Just Accepted 🔗 bit.ly/4bw4NmD

Another Point Goes to Team Short Course: Implications of the BALANCE Trial Post-Hoc Analysis for Pseudomonas aeruginosa Bloodstream Infections ✅ Just Accepted 🔗 bit.ly/4cPXZma

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal RSV infections in immunocompromised patients ✅ Just Accepted 🔗 bit.ly/3PHxtlb

A Framework for Progress: What a Phase 2 Trial Teaches Us About Mycobacterium abscessus Research ✅ Just Accepted 🔗 bit.ly/4bLWyUK

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients ✅ Just Accepted 🔗 bit.ly/4ryjJGL

Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years ✅ Just Accepted 🔗 bit.ly/4sPmTqS